APO RESEARCH · REPORT
Vinblastinesulphate
Vinblastinesulphate (CAS 143-67-9) is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
Product & engineering
Understand the product.
Vinblastinesulphate (CAS 143-67-9) is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
Selected research
Industry Research
Vinblastinesulphate Industry Research Report 2026
Market perspective
Vinblastinesulphate (CAS 143-67-9) is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
Global Vinblastinesulphate (CAS 143-67-9) key players include Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, etc. Global top four manufacturers hold a share about 60%.
China is the largest market, with a share about 40%, followed by Europe and USA, have a share over 40 percent.
Read the full market overview
In terms of product, 97-98% Vinblastinesulphate is the largest segment, with a share about 60%. And in terms of application, the largest application is Lymphoma, followed by Lung Cancer, Breast & Ovarian Cancer, Leukemia, ect.
Report Scope
This report quantifies the global Vinblastinesulphate market in revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Vinblastinesulphate.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Vinblastinesulphate Market by Company
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem
Vinblastinesulphate Segment by Type
>98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other
Vinblastinesulphate Segment by Application
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other
Vinblastinesulphate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vinblastinesulphate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vinblastinesulphate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vinblastinesulphate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Vinblastinesulphate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Vinblastinesulphate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Vinblastinesulphate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- >98% Vinblastinesulphate
- 97-98% Vinblastinesulphate
- Other
Applications
- Lymphoma
- Lung Cancer
- Breast & Ovarian Cancer
- Leukemia
- Other
Companies covered
- Guangzhou Hanfang Pharmaceutical
- Hainan Vinca Biological Medicine Technology
- Guangzhou Person Pharmaceutical
- Hainan Yueyang Biotechnology
- Hubei Honch Pharmaceutical
- Fine Chemicals Corporation
- Hengtengfu Biological Products
- Vinkem
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Vinblastinesulphate by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 >98% Vinblastinesulphate
- 2.2.3 97-98% Vinblastinesulphate
- 2.2.4 Other
- 2.3 Vinblastinesulphate by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Lymphoma
- 2.3.3 Lung Cancer
- 2.3.4 Breast & Ovarian Cancer
- 2.3.5 Leukemia
- 2.3.6 Other
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Vinblastinesulphate Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Vinblastinesulphate Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Vinblastinesulphate Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Vinblastinesulphate Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Vinblastinesulphate Production by Manufacturers (2021-2026)
- 3.2 Global Vinblastinesulphate Production Value by Manufacturers (2021-2026)
- 3.3 Global Vinblastinesulphate Average Price by Manufacturers (2021-2026)
- 3.4 Global Vinblastinesulphate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Vinblastinesulphate Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Vinblastinesulphate Manufacturers, Product Type & Application
- 3.7 Global Vinblastinesulphate Manufacturers Established Date
- 3.8 Global Vinblastinesulphate Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Guangzhou Hanfang Pharmaceutical
- 4.1.1 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate Company Information
- 4.1.2 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate Business Overview
- 4.1.3 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Guangzhou Hanfang Pharmaceutical Product Portfolio
- 4.1.5 Guangzhou Hanfang Pharmaceutical Recent Developments
- 4.2 Hainan Vinca Biological Medicine Technology
- 4.2.1 Hainan Vinca Biological Medicine Technology Vinblastinesulphate Company Information
- 4.2.2 Hainan Vinca Biological Medicine Technology Vinblastinesulphate Business Overview
- 4.2.3 Hainan Vinca Biological Medicine Technology Vinblastinesulphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Hainan Vinca Biological Medicine Technology Product Portfolio
- 4.2.5 Hainan Vinca Biological Medicine Technology Recent Developments
- 4.3 Guangzhou Person Pharmaceutical
- 4.3.1 Guangzhou Person Pharmaceutical Vinblastinesulphate Company Information
- 4.3.2 Guangzhou Person Pharmaceutical Vinblastinesulphate Business Overview
- 4.3.3 Guangzhou Person Pharmaceutical Vinblastinesulphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Guangzhou Person Pharmaceutical Product Portfolio
- 4.3.5 Guangzhou Person Pharmaceutical Recent Developments
- 4.4 Hainan Yueyang Biotechnology
- 4.4.1 Hainan Yueyang Biotechnology Vinblastinesulphate Company Information
- 4.4.2 Hainan Yueyang Biotechnology Vinblastinesulphate Business Overview
- 4.4.3 Hainan Yueyang Biotechnology Vinblastinesulphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Hainan Yueyang Biotechnology Product Portfolio
- 4.4.5 Hainan Yueyang Biotechnology Recent Developments
- 4.5 Hubei Honch Pharmaceutical
- 4.5.1 Hubei Honch Pharmaceutical Vinblastinesulphate Company Information
- 4.5.2 Hubei Honch Pharmaceutical Vinblastinesulphate Business Overview
- 4.5.3 Hubei Honch Pharmaceutical Vinblastinesulphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Hubei Honch Pharmaceutical Product Portfolio
- 4.5.5 Hubei Honch Pharmaceutical Recent Developments
- 4.6 Fine Chemicals Corporation
- 4.6.1 Fine Chemicals Corporation Vinblastinesulphate Company Information
- 4.6.2 Fine Chemicals Corporation Vinblastinesulphate Business Overview
- 4.6.3 Fine Chemicals Corporation Vinblastinesulphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Fine Chemicals Corporation Product Portfolio
- 4.6.5 Fine Chemicals Corporation Recent Developments
- 4.7 Hengtengfu Biological Products
- 4.7.1 Hengtengfu Biological Products Vinblastinesulphate Company Information
- 4.7.2 Hengtengfu Biological Products Vinblastinesulphate Business Overview
- 4.7.3 Hengtengfu Biological Products Vinblastinesulphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Hengtengfu Biological Products Product Portfolio
- 4.7.5 Hengtengfu Biological Products Recent Developments
- 4.8 Vinkem
- 4.8.1 Vinkem Vinblastinesulphate Company Information
- 4.8.2 Vinkem Vinblastinesulphate Business Overview
- 4.8.3 Vinkem Vinblastinesulphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Vinkem Product Portfolio
- 4.8.5 Vinkem Recent Developments
5 Global Vinblastinesulphate Production by Region
- 5.1 Global Vinblastinesulphate Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Vinblastinesulphate Production by Region: 2021-2032
- 5.2.1 Global Vinblastinesulphate Production by Region: 2021-2026
- 5.2.2 Global Vinblastinesulphate Production Forecast by Region (2027-2032)
- 5.3 Global Vinblastinesulphate Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Vinblastinesulphate Production Value by Region: 2021-2032
- 5.4.1 Global Vinblastinesulphate Production Value by Region: 2021-2026
- 5.4.2 Global Vinblastinesulphate Production Value Forecast by Region (2027-2032)
- 5.5 Global Vinblastinesulphate Market Price Analysis by Region (2021-2026)
- 5.6 Global Vinblastinesulphate Production and Value, YOY Growth
- 5.6.1 North America Vinblastinesulphate Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Vinblastinesulphate Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Vinblastinesulphate Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Vinblastinesulphate Production Value Estimates and Forecasts (2021-2032)
6 Global Vinblastinesulphate Consumption by Region
- 6.1 Global Vinblastinesulphate Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Vinblastinesulphate Consumption by Region (2021-2032)
- 6.2.1 Global Vinblastinesulphate Consumption by Region: 2021-2026
- 6.2.2 Global Vinblastinesulphate Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Vinblastinesulphate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Vinblastinesulphate Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Vinblastinesulphate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Vinblastinesulphate Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Vinblastinesulphate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Vinblastinesulphate Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Vinblastinesulphate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Vinblastinesulphate Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Vinblastinesulphate Production by Type (2021-2032)
- 7.1.1 Global Vinblastinesulphate Production by Type (2021-2032) & (kg)
- 7.1.2 Global Vinblastinesulphate Production Market Share by Type (2021-2032)
- 7.2 Global Vinblastinesulphate Production Value by Type (2021-2032)
- 7.2.1 Global Vinblastinesulphate Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Vinblastinesulphate Production Value Market Share by Type (2021-2032)
- 7.3 Global Vinblastinesulphate Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Vinblastinesulphate Production by Application (2021-2032)
- 8.1.1 Global Vinblastinesulphate Production by Application (2021-2032) & (kg)
- 8.1.2 Global Vinblastinesulphate Production Market Share by Application (2021-2032)
- 8.2 Global Vinblastinesulphate Production Value by Application (2021-2032)
- 8.2.1 Global Vinblastinesulphate Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Vinblastinesulphate Production Value Market Share by Application (2021-2032)
- 8.3 Global Vinblastinesulphate Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Vinblastinesulphate Value Chain Analysis
- 9.1.1 Vinblastinesulphate Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Vinblastinesulphate Production Mode & Process
- 9.2 Vinblastinesulphate Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Vinblastinesulphate Distributors
- 9.2.3 Vinblastinesulphate Customers
10 Global Vinblastinesulphate Analyzing Market Dynamics
- 10.1 Vinblastinesulphate Industry Trends
- 10.2 Vinblastinesulphate Industry Drivers
- 10.3 Vinblastinesulphate Industry Opportunities and Challenges
- 10.4 Vinblastinesulphate Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst